Clinical Trial Update: Immunotherapy Using Precision T Cells Specific to Personalized Neo-antigen for the Treatment of Advanced Malignant Tumor of Biliary Tract [Phase 1, Phase 2]

View source ↗

Summary

This update describes a Phase 1/2 clinical trial evaluating a personalized neoantigen-specific T cell immunotherapy for advanced biliary tract cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• Neoantigen-specific T cell therapy

Snippet

Sponsor: Second Military Medical University | Conditions: Advanced Biliary Tract Malignant Tumor | Phase 1, Phase 2 | Status: UNKNOWN